|
Synonyms: CPD-231 [WO2020038415] | TR-231 [WO2020038415]
Compound class:
Synthetic organic
Comment: Sovutrecdeg is the INN for a tropomyosin receptor kinase (TRK) degrader, that was included in WHO INN Proposed List 135 (July 2026). Its chemical structure indicates that it is a cereblon (CRBN)-engaging PROTAC degrader, with an entrectinib-derived moiety to bind the target of interest. It is one of the structures claimed in patent WO2020038415A1 (Cullgen Shanghai, company acquired by Gyre Therapeutics in May 2026) [1]. The lead pan-TRK protein degrader being developed by Gyre is CG001419, and although its structure has not been formally disclosed (as of July 2026), sovutrecdeg may be the proposed INN for this clinical candidate.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Ligand families/groups | PROTACs, molecular glues and other degraders |
IUPAC Name ![]() |
| N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-[4-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]azetidin-3-yl]methyl]piperazin-1-yl]-2-(oxan-4-ylamino)benzamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 14247 | sovutrecdeg |
Synonyms ![]() |
| CPD-231 [WO2020038415] | TR-231 [WO2020038415] |
Database Links ![]() |
|
| CAS Registry No. | 2412058-69-4 (source: WHO INN record) |
| GtoPdb PubChem SID | 530846895 |
| PubChem CID | 146410394 |
| Search Google for chemical match using the InChIKey | HMQGMDOSEOPTJW-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | HMQGMDOSEOPTJW |
| Search PubMed clinical trials | sovutrecdeg |
| Search PubMed titles | sovutrecdeg |
| Search PubMed titles/abstracts | sovutrecdeg |
| UniChem Compound Search for chemical match using the InChIKey | HMQGMDOSEOPTJW-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | HMQGMDOSEOPTJW-UHFFFAOYSA-N |